Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP103949.RAjyrdirz8uOjamhc_0GfQNd29FgRmevreAMKb9zCGVTI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP103949.RAjyrdirz8uOjamhc_0GfQNd29FgRmevreAMKb9zCGVTI130_assertion type Assertion NP103949.RAjyrdirz8uOjamhc_0GfQNd29FgRmevreAMKb9zCGVTI130_head.
- NP103949.RAjyrdirz8uOjamhc_0GfQNd29FgRmevreAMKb9zCGVTI130_assertion description "[The increased number of cells that expressed Oct4A in prostate cancer compared to benign prostate, and in cancers of increasing grade, suggests that Oct4A/Chromogranin A co-expressing cells represent neuroendocrine cells in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP103949.RAjyrdirz8uOjamhc_0GfQNd29FgRmevreAMKb9zCGVTI130_provenance.
- NP103949.RAjyrdirz8uOjamhc_0GfQNd29FgRmevreAMKb9zCGVTI130_assertion evidence source_evidence_literature NP103949.RAjyrdirz8uOjamhc_0GfQNd29FgRmevreAMKb9zCGVTI130_provenance.
- NP103949.RAjyrdirz8uOjamhc_0GfQNd29FgRmevreAMKb9zCGVTI130_assertion SIO_000772 19058139 NP103949.RAjyrdirz8uOjamhc_0GfQNd29FgRmevreAMKb9zCGVTI130_provenance.
- NP103949.RAjyrdirz8uOjamhc_0GfQNd29FgRmevreAMKb9zCGVTI130_assertion wasDerivedFrom lhgdn-20090331 NP103949.RAjyrdirz8uOjamhc_0GfQNd29FgRmevreAMKb9zCGVTI130_provenance.
- NP103949.RAjyrdirz8uOjamhc_0GfQNd29FgRmevreAMKb9zCGVTI130_assertion wasGeneratedBy ECO_0000203 NP103949.RAjyrdirz8uOjamhc_0GfQNd29FgRmevreAMKb9zCGVTI130_provenance.